US Patent Issued to Vanda Pharmaceuticals on Oct. 21 for "Liquid tasimelteon formulations and methods of use thereof" (Maryland, Kansas Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,447,141, issued on Oct. 21, was assigned to Vanda Pharmaceuticals Inc. (Washington).

"Liquid tasimelteon formulations and methods of use thereof" was invented by Deepak Phadke (Olathe, Kan.) and Mihael Polymeropoulos (Potomac, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Liquid suspensions of tasimelteon and methods for their use."

The patent was filed on Nov. 14, 2024, under Application No. 18/947,694.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12447141&OS=12447141&RS=12447...